Catalent, Inc. to Present at the Biopharma CEO Investor Forum
2021年6月4日 - 10:00PM
ビジネスワイヤ(英語)
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products, today announced that John Chiminski,
Chair and Chief Executive Officer, will virtually present at the
Biopharma CEO Investor Forum at 9:45 a.m. ET on June 8, 2021.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc. Catalent, Inc. (NYSE: CTLT), an
S&P 500® Company, is the leading global provider of advanced
delivery technologies, development, and manufacturing solutions for
drugs, biologics, cell and gene therapies, and consumer health
products. With over 85 years serving the industry, Catalent has
proven expertise in bringing more customer products to market
faster, enhancing product performance and ensuring reliable global
clinical and commercial product supply. Catalent employs over
15,000 people, including over 2,400 scientists and technicians, at
more than 45 facilities across four continents, and in fiscal year
2020 generated over $3 billion in annual revenue. Catalent is
headquartered in Somerset, New Jersey. For more information, visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210604005034/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
過去 株価チャート
から 6 2024 まで 7 2024
Catalent (NYSE:CTLT)
過去 株価チャート
から 7 2023 まで 7 2024